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Abstract
Bacterial auto-aggregation is a critical step during adhesion of N. meningitidis to host cells. The precise mechanisms and
functions of bacterial auto-aggregation still remain to be fully elucidated. In this work, we characterize the role of a
meningococcal hypothetical protein, NMB0995/NMC0982, and show that this protein, here denoted NafA, acts as an anti-
aggregation factor. NafA was confirmed to be surface exposed and was found to be induced at a late stage of bacterial
adherence to epithelial cells. A NafA deficient mutant was hyperpiliated and formed bundles of pili. Further, the mutant
displayed increased adherence to epithelial cells when compared to the wild-type strain. In the absence of host cells, the
NafA deficient mutant was more aggregative than the wild-type strain. The in vivo role of NafA in sepsis was studied in a
murine model of meningococcal disease. Challenge with the NafA deficient mutant resulted in lower bacteremia levels and
mortality when compared to the wild-type strain. The present study reveals that meningococcal NafA is an anti-aggregation
factor with strong impact on the disease outcome. These data also suggest that appropriate bacterial auto-aggregation is
controlled by both aggregation and anti-aggregation factors during Neisseria infection in vivo.
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Introduction
N. meningitidis is an obligate human pathogen and a causative
agent of meningitis and sepsis. The reservoir for this microbe is the
nasopharynx and up to 40% of some populations are asymptom-
atic carriers [1]. Occasionally bacteria can gain access to the
bloodstream and spread to the cerebrospinal fluid, causing sepsis
and meningitis. The prerequisite for meningococcal disease is
bacterial colonization of the nasopharyngeal mucosa. N. meningitidis
uses a two-step strategy to adhere to host cells, with an initial
attachment phase followed by an intimate adherence phase.
Initial attachment of bacteria to cells is mediated by the type IV
pili (TFP) that extend from the bacterial surface [2,3,4,5]. TFP are
thin hair-like filaments and are responsible for several virulence-
associated functions such as twitching motility, microcolony
formation, and auto-aggregation, which in turn are essential
properties for efficient initial bacteria-cell interaction (reviewed in
[6]). TFP are distributed widely among commensal, environmen-
tal and pathogenic bacteria, such as enteropathogenic E. coli,
Pseudomonas aeruginosa, Myxococcus xanthus and Haemophilus influenzae.
The importance of auto-aggregation in Neisseria infection has been
previously investigated by inactivation of one of the minor pilins,
PilX, which is necessary for pilus-pilus interaction. PilX-deficient
strains are unable to form microcolonies and show defects in
adherence to cultured mammalian cells [7]. The aggregative
properties of PilX have been linked to a ‘‘hook’’ domain in the C-
terminus that is essential for pilus-pilus (PilX-PilX) interaction [8].
After initial attachment, pili are down-regulated and microcolonies
begin to disperse. The bacteria then spread onto the cell surface as
a monolayer, which initiates intimate adherence [9]. It has been
suggested that down-regulation of pili and microcolony dispersal is
mediated by the ATPase PilT [10].
Several bacterial membrane-associated components are in-
volved in intimate bacteria-cell interaction, such as lipooligosac-
charides (LOS), the capsular polysaccharides, and outer mem-
brane proteins including opacity proteins (Opa) and the Opc
protein. LOS is an important inducer of the host inflammatory
response in meningococcal sepsis [11,12]. The capsular polysac-
charides are needed for septicaemia and meningitis [13] and are
important factors for intracellular meningococcal survival [14]. It
has been shown that down regulation of capsule is associated with
intimate adhesion of meningococci to host cells [15,16]. N.
meningitidis typically expresses four kinds of opacity proteins that
interact with host cells during intimate adherence. The Opa
proteins directly interact with the CEACAM (carcinoembryonic
antigen-related cell adhesion molecule) family of receptors
[17,18,19]. The Opc protein forms a complex with host integrins
through fibronectin or vitronectin [20,21]. Furthermore, Opa and
Opc proteins have been linked with binding to heparan sulphate
proteoglycans [18,22,23].
In this study, we investigated the role in pathogenesis of a
conserved bacterial protein, here named NafA, which is up-
regulated and surface expressed following adhesion of N. meningitidis
to host cells. NafA (NMB0995) was previously reported as a
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21749potential vaccine candidate component for serogroup B strains [24].
We demonstrate that NafA acts as an anti-aggregation factor at the
bacterial surface preventing excess auto-aggregation and microcol-
ony formation during colonization of epithelial cells. Furthermore,
the anti-aggregation property mediated by NafA is shown to
enhance N. meningitidis virulence in a murine disease model.
Results
NafA is 19 kDa and highly conserved among Neisseria
species.
In recent years, genomic and transcriptional studies of
pathogenic bacteria have highlighted a large set of hypothetical
proteins, to which specific biological functions have not been
allocated. One such protein is hypothetical protein NMB0995
(NCBI Reference Sequence: NP_274031.1) in N. meningitidis
serogroup B strain MC58. NMB0995 is here named NafA for
Neisseria anti-aggregation factor A (see below). It has been shown
that NafA displays low levels of genetic variation in tested
meningococcal strains, is up-regulated in FACS analyses upon
bacterial adhesion to host cells, and that murine antibodies raised
against full-length NafA are bactericidal against N. meningitidis [24].
To investigate the role of NafA in meningococcal virulence, we
generated and purified rabbit antibodies against three regions of
NafA (Fig. 1A). Whole cell lysates of N. meningitidis serogroup C
strain FAM20 were analysed by western blotting using the purified
anti-NafA antibodies. The western blot results indicated a specific
protein band with a molecular mass of 19 kDa (Fig. 1B), whilst the
expected theoretical size of NafA was 227 amino acids, i.e.
24.2 kDa (Fig. 1A). Therefore interspecies NafA reference
sequences were analyzed and aligned (Fig. 1C). The protein was
found to be highly conserved among different Neisseria species,
including the pathogen N. gonorrhoeae, and the human specific
commensal species such as N. sicca, N.cinerea, N. lactamica, N.
flavescens, N. mucosa, and N. subflava (Fig. 1C). The sequence identity
among reported NafA homologues is at least 90%. NafA of MC58,
i.e. NMB0995 (2. NP_274031 in Fig. 1C) and NafA of serogroup C
FAM18 strain, i.e. NMC0982 (1. YP_975044 in Fig. 1C) share
99.6% sequence identity with a predicted 227 amino acid coding
region corresponding to a theoretical molecular mass of 24.2 kDa.
The sequence corresponding to the first 45 N-terminal residues
was absent from 3 of 19 neisserial sequences but present in 3 of 4
meningococcal sequences, suggesting a miss-annotation of these
sequences. Taken together, these results strongly suggest that
native NafA is 182 amino acids long with the actual start codon at
amino acid 46 of the originally annotated sequence, and not 227
amino acids as previously reported.
NafA is surface expressed upon meningococcal
attachment to human cells
Several lines of evidence have demonstrated that expression of
certain meningococcal outer membrane components is regulated
upon contact with the host epithelium, thereby facilitating
meningococcal colonization [15,25]. NafA was previously detected
on the bacterial surface by flow cytometry after ethanol
permeabilization of the bacterial capsule [24]. To further monitor
regulation of NafA and to visually determine its localization during
bacteria-host cell interaction, we infected the human pharyngeal
epithelial cell line FaDu with N. meningitidis FAM20 for 2 h and 6 h
and analyzed the NafA expression by fluorescence microscopy
using an anti-NafA antibody. At an early adhesion stage, i.e. 2h
post infection, we could not observe any specific staining (Fig. 2).
However, at 6 h post infection, specific fluorescent signal of NafA
could clearly be detected at the bacterial surface (Fig. 2, Fig. S4).
These results argue that NafA becomes surface exposed at a later
stage of bacterial adhesion to host cells, i.e. after 6 h of infection.
NafA affects bacterial piliation
To investigate the function of NafA in Neisseria infection, we
generated a NafA deficient mutant, DNafA, by replacing nafA with
a kanamycin resistance cassette. A complemented strain, DNafA/
NafA, was also constructed by introducing a copy of the nafA gene
into a noncoding genomic region of the DNafA strain (see
Experimental Procedures). The mutant and the complemented
strain showed similar growth rate and colony morphology when
compared to the wild-type strain (data not shown). Western blot
analysis of outer membrane protein fractions (OMP) and whole
cell lysates confirmed the absence of NafA in the mutant and
showed that the complemented strain had regained NafA
expression (Fig. 3A and B). To verify that the mutant was
unaffected in the expression of major virulence factors, we
analyzed whole cell lysates by western blot. There were no
detectable differences in expression of Opa proteins, PilC, PilQ, or
PilT when comparing the wild-type, the DNafA, and the
complemented strains (Fig. 3B). However, the normalized intensity
of the PilE-reactive band was 1.5-fold higher in the DNafA strain
than that in the wild-type strain (Fig. 3C). Following this western
blot, the amounts of pili on the bacterial surface were investigated
by whole bacterial ELISA with an anti-pili antibody. We
confirmed our PilE western blot result by finding that significantly
more pili were expressed on the surface of the DNafA strain than
on the wild-type strain (Fig. 3D). However, there were no
differences in pilE gene mRNA amounts between the wild-type
strain and the DNafA strain, as measured by a quantitative PCR
assay (Fig. 3E).
Because pili play an important role in bacterial microcolony
formation, transmission electron microscopy was used to evaluate
whether NafA had any influence on cell or pilus morphology of N.
meningitidis. As shown in Fig. 4, the DNafA strain expressed thick
bundles of pili with an average length exceeding 20 mm (Fig. 4B
and C, black arrowheads), whereas the wild-type strain lacked
extended pilus bundles (Fig. 4A). We looked at more than 20 areas
for each strain. Each area contained 10 – 30 diplococci. The thick
bundles of pili, which associated with more than 10 diplococci as
shown in Fig. 4C, was found in all areas of the DNafA strain. In
contrast, we found no thick bundles of pili in the wild-type
specimen. These results suggest that NafA controls piliation
properties at the post-transcriptional level by preventing excessive
bundling of pili.
NafA prevents massive aggregation during
meningococcal attachment to host cells
Colonization of epithelial cell surfaces is an essential early step
in meningococcal infection processes and pili play a crucial role
during the initial bacterial attachment to host cells. To examine
whether NafA affects pilus-mediated attachment, FaDu cells were
infected with the wild-type strain or the DNafA strain for 2 h. The
infected cells were then fixed and stained by an anti-N. meningitidis-
pilus antibody, which also stains the whole N. meningitidis cell in
immunofluorescence. When compared to the wild-type strain, the
DNafA strain formed much larger microcolonies on the host cell
surface accompanied by an increase in overall fluorescence
intensity (Fig. 5A). Furthermore, network-like pilus structures
were often seen in microcolonies of the DNafA strain, indicating
the formation of thick bundled pili (Fig. 5A, arrows, inset in top
row). The microcolonies formed by the complemented strain
(DNafA/NafA) showed a pattern of staining comparable to the
wild-type strain (Fig. 5A, right column). The bacterial adhesion
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removal of unbound bacteria. As expected, significantly higher
numbers of the DNafA strain were recovered from host cells
compared to the wild-type strain. The enhanced attachment
displayed by the DNafA strain was attenuated in the comple-
mented strain (Fig. 5B). It has been shown that the antigenic
variation of pilin strongly affects adhesiveness of N. meningitidis to
human epithelial cells [26,27]. These reports led us to examine the
Figure 1. NafA is a highly conserved protein among Neisseria species. A. Schematic representation of NMC0982 (NafA). Regions
corresponding to the three peptides used as immunogens are indicated. A transmembrane domain (TM) predicted by the TMpred program (http://
www.ch.embnet.org/software/TMPRED_form.html) is indicated as blue colour at the C-terminal. B. NafA was detected in whole cell lysate of FAM20
wild-type strain by western blot (w) using each peptide-generated antibody. The specific signal of NafA is indicated with an asterisk. Developed
membranes (m) stained with amino black are also shown. C. BLAST alignment of NafA homologues from 19 different Neisseria strains and species,
ordered by identity. The identity between NMC0982 (1. YP_975044) and NGO0887 (19. YP_207998) is 90.1%.
doi:10.1371/journal.pone.0021749.g001
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strain, and DNafA/NafA strain. However, there were no sequence
differences in pilE genes among the strains, showing that the high
adhesiveness of the DNafA strain was not due to antigenic
variation in pilE.
These results suggest that NafA negatively regulates bacteria-
host cell interactions by reducing microcolony formation and
excessive pilus aggregation, in a pilE sequence independent
manner.
NafA-mediated anti-aggregation is host cell independent
To examine whether the enhanced microcolony formation of
the DNafA strain was host cell-dependent, bacteria were grown in
different liquid conditions, i.e. GC-liquid media, Dulbecco’s
modified Eagle’s medium (DMEM) with and without 1% fetal
calf serum (FCS). Bacterial aggregation was observed over a period
of 6 h. After 30 min of incubation in GC-liquid or 120 min of
incubation in DMEM containing FCS, small bacterial aggregates
were observable for the DNafA strain (Fig. 6A and 6B, arrows),
whilst most of the wild-type strain was still present as single
diplococcus. When DMEM without FCS was applied, the DNafA
strain started to form loose aggregates after 60 min of incubation
(Fig. 6C, arrow) and spherical bacterial aggregates could be
detected after 180 min of incubation (Fig. 6C, arrowhead). The
wild-type strain was unable to form spherical aggregates even after
360 min of incubation in this medium. The complemented strain
(DNafA/NafA) showed a capacity to form aggregate comparable
with the wild-type strain under all conditions studied. To quantify
the bacterial aggregation, we also performed a previously
described sedimentation assay [7]. Strains were cultured in either
GC liquid medium or DMEM for 150 min with shaking. The
cultures were then left to sediment at room temperature without
shaking. OD600 values of the DNafA culture supernatant were
significantly lower than that of the wild-type strain from the 150 to
210 min time points of GC liquid medium and from the 150 to
420 min time points in DMEM without FCS, representative assay
are shown in Fig. 7. These results suggest that NafA negatively
controls the formation of bacterial aggregates also in the absence
of host cells.
NafA enhances bacterial virulence and survival in blood
Sepsis and meningitis are the major clinical features of
meningococcal disease. To examine the impact of NafA during
N. meningitidis disease in vivo, we challenged CD46 transgenic mice
intraperitoneally (i.p.) with the DNafA and the wild-type strains.
Blood samples were collected at indicated time points to monitor
levels of bacteremia. At 2 h post infection, there was no significant
difference in bacteremia levels between the wild-type strain and
the DNafA strain (Fig. 8A), indicating that the mutant retained an
ability to invade and survive in blood. At 6 h and 24 h post
infection, the bacterial blood counts in mice challenged with the
DNafA strain were significantly lower than in mice infected with
the wild-type strain (Fig. 8A). The DNafA strain was also
attenuated in its ability to cause lethal disease when compared
to the wild-type strain. At 2 days post-infection nearly all mice (11
out of 12) challenged with the wild-type strain had a lethal
outcome, while around 60% (7 out of 12 mice) of the mice infected
with the mutant survived (Fig. 8B). These results suggest that
expression of NafA contributes to bacterial survival in blood and
consequently facilitates the development of lethal sepsis in the host.
To confirm this hypothesis, the role of NafA in an ex vivo whole
blood was investigated. Suspensions of the wild-type, the DNafA,
and the DNafA/NafA strains, containing equal amounts of CFU,
were incubated for 1 h, 3 h, or 6 h in whole blood collected from
CD46 transgenic mice. Fig. 8C-E shows a 50% reduction in viable
counts of the DNafA mutant when compared to the wild-type at
the 1 h and 3 h time points. No difference could be detected
between the complemented strain and the wild-type strain. To
evaluate whether the DNafA strain in more sensitive to
complement-mediated killing, bacterial strains were grown in
50% of serum collected from CD46 transgenic mice and incubated
for 1 h. However, we did not observe any growth differences
between the wild-type and the DNafA strain under these
conditions (data not shown). Taken together, these results suggest
that NafA, which is not involved in the protection from
complement attack, facilitates bacterial survival in the bloodstream
and contributes to meningococcal virulence.
Discussion
The NafA (NMB0995) protein was first identified as an antigen
with the capacity to induce bactericidal antibodies in mice [24].
Upon interaction with epithelial cells, expression of NafA
increased and the protein could be detected at the bacterial
surface, indicating that NafA might play an important role in the
bacteria-host cell interaction. In this study, we investigated the
impact of this protein on bacterial pathogenesis by using an
isogenic NafA-deficient mutant strain (DNafA). We demonstrate
that NafA negatively regulates pilus expression and plays a
determining role in bacterial aggregation and disease develop-
ment.
In order to generate a DNafA strain, we applied a MultiSite
Gateway Three-Fragment Vector Construction system. This
system can also be used to express exogenous genes in Neisseria,
as demonstrated by the strategy used for construction of the
complemented strain (DNafA/NafA). For the complementation of
Figure 2. NafA is induced and exposed at the bacterial surface
upon host cells interaction. FaDu cells were infected with the wild-
type strain for 2 h (left column) or 6 h (right column). After washing
away unbound bacteria, the cells were stained with anti-NafA peptide N
antibody. Fluorescent (upper row) and Nomarski (lower row) images are
shown. A 100 x objective lens was used. The inset shows higher
magnification of the boxed area in the image. Arrow indicates a
microcolony on the cell.
doi:10.1371/journal.pone.0021749.g002
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5-porA-pro and pDONR P2R-P3 CmR-3 to facilitate introduc-
tion of exogenous gene into a non-coding chromosomal region
(Fig. S1 and S2). These two plasmids are universally useful to
express genes under the porA promoter. We were also successful in
expressing other genes, such as egfp derived from pEGFP-C1, in N.
meningitidis FAM20, and it was possible to modulate gene
expression by introducing a consensus ribosomal binding sequence
Figure 3. The DNafA strain expresses more PilE protein than the wild-type strain. Bacterial outer membrane proteins (A) and whole cell
lysate samples (B) were prepared from strains indicated and separated by SDS-PAGE. A. Expression profiles of outer membrane protein were detected
by Coomassie Brilliant Blue staining. PorB and Opa proteins were confirmed by MALDI-TOFMS. The lower panel shows the expression of NafA and
Opa proteins in the outer membrane fraction, as detected by western blot analysis using anti-NafA peptide C antibody and anti-All Opa antibody,
respectively. Arrows indicate non-specific bands (NS). B. Detection of NafA, Opa proteins and pilus components from whole bacterial lysate samples
by western blot analysis. Equal amounts of whole cell lysates were loaded in each western blot analysis. C. The western blot analysis was performed
as panel B. The signal intensities were analyzed using ImageJ software and relative value were presented when value of the wild-type strain was set
as 1.0. D. Amounts of PilE produced by indicated strains were compared by whole cell ELISA using anti-pili (which mainly recognizes PilE, see
Experimental procedures). The histogram shows the relative PilE expression levels of bacterial strains, OD450 value of the wild-type strain was set as 1.0.
The error bars in C and D represent standard error of mean (SEM) from triplicate experiments. Statistically significant difference is indicated with
single asterisk (P,0.05) or triple asterisks (P,0.001). E. Level of pilE mRNA were compared by quantitative RT-PCR. The histogram shows relative pilE
mRNA levels normalized to the housekeeping genes, NMC0139 (50S ribosomal protein rplP; left three bars) or NMC0129 (30S ribosomal protein rpsJ;
right three bars), and calculated in arbitrary units set to a value of 1 for the wild-type strain. The experiments were repeated using samples generated
from two separate cDNA synthesises. Also, cDNA synthesized from a separate RNA preparation gave similar results (data not shown).
doi:10.1371/journal.pone.0021749.g003
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this study, with any other promoter without major effort.
The levels of PilE and pili in the DNafA strain, as determined by
western blot and whole-cell ELISA, were higher than that in the
wild-type strain (Fig. 3). Transmission electron microscopy further
showed that the DNafA strain formed thick bundles of pili, which
linked several bacterial cells together (Fig. 4). These results
demonstrate that NafA negatively contributes to bacterial
adhesion (Fig. 5) and aggregation (Fig. 6 and 7), possibly by
preventing excess pilus bundling. The difference in pili amounts
on bacterial surfaces between the wild-type strain and the DNafA
strain was unexpectedly little in the whole-cell ELISA (Fig. 3D).
The reason could be speculated that the thick bundled pili of
DNafA strain can be physically washed out more easily than wild-
type pili during ELISA experiment.
The closest non-Neisseriaceae family orthologue of NafA is a H.
influenzae hypothetical protein (locus tag: CGSHi3655_03561),
sharing less than 60% identity to NafA, and it would be of great
interest to find out if the anti-aggregative property of NafA is
Neisseria-specific. The ATPase PilT is the sole component directly
responsible for depolymerisation (i.e. retraction) of the pilus
filament. PilT deficient mutants of Neisseria are hyperpiliated,
hyperaggregative and display increased adherence to the host cell.
However, PilT mutants display irregularly shaped aggregates, are
non-motile, and lack natural competence [10,28,29,30]. The
DNafA strain forms spherical aggregates (Fig. 6) and retains
natural transformation competence, as shown by the creation of
the DNafA/NafA complemented strain. Furthermore, the DNafA
strain displayed normal PilT expression (Fig. 3B) and motility (data
not shown), indicating that NafA regulates bacterial piliation and
auto-aggregation through a distinct mechanism.
The induction of NafA could only be detected by fluorescence
microscopy at 6 hours post infection, but western blots of outer
membrane fractions indicate that low amounts of NafA are
constitutively expressed at the bacterial surface (Fig 3A). NafA
lacks a typical signal peptide sequence, but contains a predicted
transmembrane domain between amino acid 104–126 at the C-
terminal part (Fig. 1B), as analyzed by the TMpred program
(http://www.ch.embnet.org/software/TMPRED_form.html). The
detailed molecular mechanisms of NafA translocation to the bac-
terial surface remain to be elucidated. The reason for the finding
that the complemented strain still shows higher adhesiveness than
the wild-type strain is unclear. The nafA gene in the complemented
strain is controlled under porA promoter, and is integrated into the
noncodingregion that is far from the original locus.These situations
might affect the efficient transportation of NafA in the comple-
mented strain.
Survival of bacteria in blood is a prerequisite for meningococ-
cal disease. Several mechanisms are used by N. meningitidis to
enhance its survival in the host bloodstream, including expression
of capsule [31] and certain outer membrane proteins [32]. We
have earlier developed an animal model of N. meningitidis infection
using human CD46 transgenic mice [33,34]. Although the role of
CD46 in Neisseria infection is still not absolutely clear [35,36], the
model is working [37] and is today to our knowledge the best
available in vivo meningococcal infection model system. Bacterial
loads in the circulation system 2 h post infection suggested that
NafA deficiency had no influence on the traversal of bacteria
from peritonea to the bloodstream. However, infection with the
DNafA strain resulted in lower levels of bacteremia at late time
points when compared to the wild-type strain. This led us to
examine if NafA conferred resistance to whole blood mediated
Figure 4. NafA regulates bacterial piliation. Piliation of the wild-type strain (A) and the DNafA strain (B, C) was analyzed by transmission
electron microscope after negative staining. White arrows mark membrane blebs and black arrows mark pili. Arrowheads in panel B and C indicate
thick bundled pilus structures. The inset in panel B shows a higher magnification of the boxed area, which displays the bundled pili. An overview of
the DNafA strain piliation is shown in panel C. Black scale bars show 0.5 mm and white scale bars 50 nm.
doi:10.1371/journal.pone.0021749.g004
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strain showed increased survival when compared to the DNafA
strain (Fig. 8C and 8D). However, both strains grew at a
comparable level in mouse serum indicating that the anti-
aggregation function of NafA could augment bacterial spreading
and escape from phagocyte-mediated bacterial killing. It has been
described that post-transcriptional modification of pili can affect
bacterial opsonisation and by this mechanism enhance bacterial
uptake by human phagocytes [38]. Thus, NafA could play a
similar, indirect, role in protecting bacteria from phagocytosis. It
is worth noting that the DNafA strain forms microcolonies much
quicker than the wild-type strain, even when we filtered the
bacterial suspensions before animal challenge. Therefore, the
bacterial number of the DNafA strain we challenged to the mice
(Fig. 8A and 8B) might be higher than that of the wild-type strain.
However, mice challenged with the DNafA strain displayed better
survival suggesting that negative modulation of bacterial
aggregation is important for bacterial survival during systemic
infection.
This study reveals an important role of NafA in bacteria-host
cell interaction and suggests that bacterial microcolony formation
is regulated by both positive, such as PilX, and negative, such as
NafA, aggregation factors.
In conclusion, we find that in order to separate aggregated
bacteria formed during initial attachment, NafA is expressed at the
bacterial surface, and that appropriate separation of bacterial cells
seems to enhance bacterial survival in blood. We further
hypothesize that NafA suppresses the excess accumulation of
extracellular pilin and that in the absence of NafA, pilin secretion
increased, protecting extracellular pilin from degradation. The
increased secretion of pilin causes a lowered intracellular
concentration of pilE, which in turn does not seem to be subjected
to positive auto-regulation, as has been hypothesized for N.
gonorrhoeae MS11 [39].
Materials and Methods
Ethics Statement
Mice experiments described in the present study were
conducted at the animal facility of Stockholm University. Animal
care and experiments were conducted adhering to the Swedish
guidelines for animal husbandry. All protocols were approved by
the Swedish Ethical Committee on Animal Experiments (Approval
ID: N380/08).
Bacterial strains, cell culture, and growth conditions
The wild-type strain used in this study was N. meningitidis
serogroup C FAM20 [40]. PilT-deficient mutant (DPilT) were
derived from FAM20 [29]. Neisseria strains were grown on GC
agar plates [41] or in GC liquid media containing 1% Kellogg’s
supplement [42] at 37uC in a 5% CO2 atmosphere. E. coli DH10B
(Invitrogen) was used for cloning. For selection of N. meningitidis
transformants, kanamycin and chloramphenicol was added to
culture media at the concentration of 100 and 2 mg/ml,
Figure 5. NafA negatively affects meningococcal attachment to host cells. A. FaDu cells were infected with the wild-type strain, the DNafA
strain, or the DNafA/NafA strain for 2 h (moi=200). After washing and fixation, the cells were stained with an anti-N. meningitidis pili antibody, which
also stains the whole bacterial surface. Cell nuclei were stained with DAPI. The images were acquired with 40 x (upper two rows) and 100 x (lower two
rows) objectives. Signals from anti-pili channel (‘‘bacteria’’) and merged images with DAPI stained cells (‘‘merge’’) are shown. Arrows and arrowheads
indicate the pilus network-like structures and pilus fibres, respectively. B. FaDu cells at 2.5610
4 cells/well in 24-well plates were infected with 5610
6
bacteria (moi=200). After 2 h of infection, 460.07610
4 bacteria were recovered from wells infected with the wild-type strain, i.e. about 1% of input
bacteria were adhered to host cells. Adhesion of the bacterial strains in panel A was quantified and expressed as ratios relative to the wild-type strain,
which was defined as 1. The error bars represent SEM of triplicate experiments. Statistically significant difference in adherence is indicated with two
asterisks (P,0.001) or one asterisk (P,0.05).
doi:10.1371/journal.pone.0021749.g005
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DMEM (Invitrogen) supplemented with 10% heat-inactivated
FCS. Unless stated otherwise, all experiments were performed
using 80% confluent cells cultivated in 24-well cell culture plate
(105 cells/well).
Generation of anti-NafA antibodies
To prepare the anti-NafA antibodies, the peptides N, M, and C
(Fig. 1B) corresponding to the amino acid residues 10 – 31
(CETAPEAAKARVEAVLQNNGFIP), 97 – 113 (CQSVKAAR-
ALAAGEFDDA), and 128 – 144 (CKKGAVSDDELKAFFDAG)
of NafA were conjugated separately with hemocyanin from
keyhole limpets (Sigma). A cysteine residue was added at the N-
terminal of each peptide in order to cross-link the carrier protein.
The cross-linked peptides were used to immunize rabbits. In order
to obtain specific immunoglobulin fractions, all antisera obtained
were absorbed once with the peptide immobilized on the epoxy-
activated sepharose 6B (GE Healthcare).
Adherence assays
Bacterial colonies grown overnight on GC agar plates were
suspended into DMEM cell culture media and filtered through a
5 mm-pore filter to obtain separated bacteria. The FaDu cells were
infectedwithbacteriaatamultiplicityofinfection(moi)of200.After
a 2 h incubation at 37uC in a 5% CO2 atmosphere, unbound
bacteria were washed away with phosphate-buffered saline (PBS),
the cells were then lysed with 1% saponin in GC-liquid media for
5 min. Lysates were plated onto GC agar plates, incubated
overnight and CFU were counted. For immunofluorescence, FaDu
cells were cultured on cover slides (In vitro diagnostics) and infected
with bacterial strains for 2 h and 6 h at 37uC in a 5% CO2
Figure 6. NafA regulates bacterial aggregation. The wild-type
strain, the DNafA strain, or the DNafA/NafA strain was suspended in GC-
liquid (A), DMEM with 1% FCS (B), and DMEM without FCS (C). The
formation of bacterial aggregates was analyzed at indicated time points
using a living-cell microscope at 37uC in an atmosphere of 5% CO2.
Arrows in panel A and B indicate small bacterial aggregates. The arrow
and arrowhead in panel C show a loose and a spherical bacterial
aggregate, respectively.
doi:10.1371/journal.pone.0021749.g006
Figure 7. Quantification of bacterial aggregation. Aggregation
was quantified by measuring the decrease in absorbance that occurs
upon sedimentation of bacterial aggregates in GC liquid medium (A) or
DMEM (B) under static conditions. Apparent differences in OD values
(0–160 min) were due to aggregative properties, not due to growth
rates.
doi:10.1371/journal.pone.0021749.g007
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fixed with 3.7% formaldehyde, stained with an anti-N. meningitidis
pili antibody or anti-NafA antibody. The secondary antibody
applied was an anti-rabbit IgG-Alexa 488 (Invitrogen) and DNA
was visualized by DAPI staining. Images were captured using an
inverted Zeiss Axio Observer microscope. Each experiment was
independently repeated for at least three times.
Generation of the NafA mutant
Primers used in this study are shown in Table 1. The MultiSite
Gateway Three-Fragment Vector Construction Kit together with
the adaptor PCR method of the Gateway cloning system
(Invitrogen) was used to construct the NafA deficient mutant. A
574 bp upstream region of the nafA gene was amplified from
FAM20 with the primers B4-NMC0982 and B1R-NMC0982.
The resulting PCR product was cloned into pDONR P4-P1R to
obtain pDONR P4-P1R DnafA. A 555 bp downstream region of
the nafA was amplified with the primers B2R-NMC0982 and B3-
NMC0982. The resulting PCR product was cloned into pDONR
P2R-P3 to obtain pDONR P2R-P3 DnafA. A 1075 bp DNA
fragment containing a kanamycin resistance gene was amplified
from plasmid pDONR P4-P1R with the primers B1-KmR and
Figure 8. The DNafA strain displayed attenuated virulence during systemic infection. Human CD46 transgenic mice were infected i.p. with
the wild-type strain (closed circles) or the DNafA strain (open circles) at a dose of 1610
8 CFU/mouse. A. Bacterial counts in blood (CFU/ml) were
determined at 2 h, 6 h, and 24 h after challenge with each strain. Challenge with the DNafA strain resulted in lower levels of bacteremia than the
wild-type strain at 6 h and 24 h post-infection. Statistically significant lower bacteremia compared to the wild type strain at each time point is
indicated with an asterisk (P,0.05) or three asterisks (P,0.001). B. Survival rate of mice (n=12 per group) after i.p. infection with the wild-type strain
or the DNafA strain. The overall survival rates of the mice infected with the mutant were significantly lower (P,0.001) than those of the wild-type
strain. C–E. Bacterial survival in whole blood collected from the human CD46 transgenic mice. Around 100 CFU bacteria were mixed with 10 ml whole
blood at a 1:1 volume ratio and incubated at 37uC in a 5% CO2 atmosphere for 1 h (C), 3 h (D), and 6 h (E). Bacteria were spread on GC agar plates
and surviving bacteria were counted after overnight incubation. The data are presented as means 6 S.E. of three independent experiments done in
triplicate. Asterisk indicates significant difference (P,0.05). N.S. represents no significant difference.
doi:10.1371/journal.pone.0021749.g008
Neisseria NafA Is Required for Severe Bacteremia
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e21749B2-KmR. The resulting PCR product was cloned into pDONR
201 to obtain pDONR KmR. Above constructed plasmids
pDONR P4-P1R DnafA, pDONR KmR, and pDONR P2R-P3
DnafA were mixed with pDEST R4-R3 (Invitrogen) and LR
Clonase Plus Enzyme in order to connect all cloned fragments, i.e.
the upstream region of nafA gene, the kanamycin resistance gene,
and the downstream region of nafA gene, in order. The resulting
plasmid designated pDEST-DnafA-KmR was inserted into the
genome of FAM20 by homologous allelic replacement after
transformation [43]. The replacement of the nafA by the
kanamycin resistance gene was confirmed by PCR and western
blot. The nafA-deficient strain was designated DNafA.
Complementation of DNafA
The DNafA strain was complemented by introducing a wild-
type gene copy into a non-coding genomic region between
NMC0075 and NMC0080 by homologous allelic replacement
[43]. The MultiSite Gateway Three-Fragment Vector Construc-
tion Kit and the adaptor PCR were applied as described above. A
502 bp fragment containing whole NMC0075 ORF (upstream
region of the insertion) was amplified from FAM20 with the
primers B4-DUS-5, which contains a DNA uptake sequence [44],
and 5-porA-pro-L. A 324 bp fragment containing the transcrip-
tional promoter for porA gene was amplified with the primers 5-
porA-pro-U and B1R-porA-pro. The NMC0075 fragment and the
porA promoter fragment were connected by PCR done in two
steps, ten cycles without any primers followed by the adapter PCR
cycle with B4 and B1R universal primers (Invitrogen). The
combined fragment was cloned into pDONR P4-P1R, which
resulted in plasmid pDONR P4-P1R 5-porA-pro (Fig. S1). An
1118 bp fragment containing the chloramphenicol resistance gene
was amplified by PCR with the primers B2R-Cm-U and Cm-3-L
using pDONR 201 plasmid DNA as the template. A 515 bp
fragment containing the upstream region of NMC0080 (down-
stream region of the insertion) was amplified from FAM20 with
the primers Cm-3-U and B3-3. The chloramphenicol resistance
gene fragment and the NMC0080 region fragment were
connected by PCR using B2R and B3 universal primers
(Invitrogen) as described above. This combined fragment was
cloned into pDONR P2R-P3, which resulted in plasmid pDONR
P2R-P3 CmR-3 (Fig. S1). An 858 bp DNA fragment containing
full-length nafA gene was amplified with the primers B1-
NMC0982-comp and B2-NMC0982-comp. The resulting PCR
product was cloned into pDONR 201 (Invitrogen) to obtain
pDONR nafA (Fig. S2). The three plasmids obtained, such as
pDONR P4-P1R 5-porA-pro, pDONR nafA, and pDONR P2R-
P3 CmR-3 were mixed with pDEST R4-R3 together with LR
Clonase Plus Enzyme to combine the NMC0075 region, porA
promoter fragment, nafA gene, the chloramphenicol resistance
gene, and NMC0080 region in order. The resulting plasmid,
designated pDEST-nafA-comp (Fig. S2), was then introduced into
N. meningitidis DNafA genome by transformation. The correct
integration of nafA gene was confirmed by PCR and western blot.
The complemented strain was designated DNafA/NafA.
Western blot analysis
Expression of NafA and other virulence related factors were
detected by western blot. Anti-Opa mouse monoclonal antibodies
Table 1. Primers used for cloning.
Name Sequence of primer pairs
B4-NMC0982 59-ATAGAAAAGTTGGCAAGGCGAGGTAACGCCGTACTGG-39
B1R-NMC0982 59-TGTACAAACTTGTTAAATGCCGTCTGAACATTTTTCAGAC-39
B2R-NMC0982 59-TGTACAAAGTGGATGGAAATCAACCCCGAATTGCAGGCTTACG-39
B3-NMC0982 59-ATAATAAAGTTGTTTGCCTTGCAGGATGTCGGCAAGG-39
B1-KmR 59-AAAAAGCAGGCTGTATTAGTGACCTGTAGAATTCGAGC-39
B2-KmR 59-AGAAAGCTGGGTTTAGAAAAACTCATCGAGCATCAAATG-39
B4-DUS-5 59-ATAGAAAAGTTGATGCCGTCTGAAAATTAAGTTAGAATTATCCC-39
5-porA-pro-L 59-CGCGGCACTTTAAAATCCAAAATCATACTGCC-39
5-porA-pro-U 59-GATTTTGGATTTTAAAGTGCCGCGTGTGTTTTTTTATGGC-39
B1R-porA-pro 59-TGTACAAACTTGATCTGCTTCCTTTTGTAAATTTGATAAAAACC-39
B2R-Cm-U 59-TGTACAAAGTGGCTAAGTTGGCAGCATCACCC-39
Cm-3-L 59-TGGTATCCGACCATATTGACATCATATATGCC-39
Cm-3-U 59-TGATGTCAATATGGTCGGATACCAATCTGACG-39
B3-3 59-ATAATAAAGTTGCTAACAGAAAACTCTACTCC-39
B1-NMC0982-comp 59-AAAAAGCAGGCTTCGGCGCAAAGGGCAACAGCC-39
B2-NMC0982-comp 59-AGAAAGCTGGGTTCAGGCGTAAGCCTGCAATTCGGGG-39
pilE-U 59-TATTCCGACAACGGCACATTCCC-39
pilE-L 59- CCTTCAACCTTAACCGATGCCA-39
rpsJ-U 59-TTGGAAATCCGCACCCACTT-39
rpsJ-L 59-TACATCAACACCGGCCGACAAA-39
rplP-U 59-GTGGCGGTAAAGGTAACGTGGAAT-39
rplP-L 59-TCGAATGCTTCACGAGCCAGTT-39
*The DNA uptake sequence is marked in italic.
The overlapping homologous sequence for combined PCR is underlined.
doi:10.1371/journal.pone.0021749.t001
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antibodies were applied as primary antibody. Horseradish perox-
idase (HRP) conjugated anti-mouse or rabbit IgG (Bio-Rad) was
used assecondaryantibody.ECL(PerkinElmer)andaCCDcamera
(Fujifilm) were used to detect the signals. Signal intensities of bands
were measured by ImageJ (http://rsbweb.nih.gov/ij/) software.
To prepare whole bacterial protein extracts, colonies grown
overnight on GC plates were suspended in PBS and adjusted to
OD600 1.0. One ml of the bacterial suspension was mixed with
100 ml of 100% trichloroacetic acid followed by 15 min incubation
on ice. After 5 min centrifugation at 20,000 x g, the pellet was
dissolved in SDS-PAGE sample buffer. Outer membrane protein
fractions were obtained according to a protocol described
previously [46]. In brief, bacteria suspended in LiCl buffer (0.2
M LiCl, 0.1 M sodium acetate, pH 5.8) were vigorously shaken
with 4 mm diameter glass beads. After centrifugation, superna-
tants were subjected to ultracentrifugation at 100,000 x g for 2 h.
The pellets were then dissolved in the SDS-PAGE sample buffer.
OMP analysis and western blots were repeated for at least three
times using the samples prepared independently.
Whole cell ELISA
The ELISA was performed as described previously [29]. Wells
of 96-well microtiter plates were coated with 50 ml of bacteria
suspension in PBS (OD600=0.01) for 2 h at room temperature,
blocked with 5% bovine serum albumin for 2 h at room
temperature. After 2 h incubation at room temperature with
anti-pili antibody used in the western blot analyses of this study,
HRP-conjugated anti-rabbit antibody was added as secondary
antibody. The plates were then incubated for 2 h at room
temperature, and plate-bound peroxidase was detected using
TMB (3, 39,5 ,5 9-tetramethylbenzidine) and stop solution. Finally
OD450 of each well was measured using a plate reader.
mRNA analysis by quantitative PCR
Neisseria strains were grown on GC plates for 18 hours. Total
RNA was isolated using a modified protocol for the SV Total
RNA Purification kit (Promega) including initial phenol/ethanol
incubation on ice to stabilize the RNA and prevent degradation.
RNA yield and quality was assessed using NanoDrop 8000.
Template RNA (150 ng) from each strain was reverse-transcribed
into cDNA with random hexamers using Superscript III First-
Strand Synthesis (Invitrogen). The resulting cDNA (0.1 ml) was
amplified using LightCyclerH 480 SYBR Green I Master kit
(Roche Diagnostics) together with pilE primers, NMC0129 (rpsJ;
30 S ribosomal protein) primers and NMC0139 (rplP; 50S
ribosomal protein) in a LightCyclerH 480 Real-Time PCR System
(Roche Diagnostics). Primer pairs specific for pilE (pilE-U and
pilE-L), NMC0129 (rpsJ-U and rpsJ-L) and NMC0139 (rplP-U
and rplP-L) were used at a final concentration of 500 nM. PCR
program was adapted from LightCyclerH 480 SYBR Green I
Master kit (Roche Diagnostics) with an annealing temperature of
60 uC. Data analysis was performed with the LightCyclerH 480
Software 1.5 using the comparative cycle threshold method, in
which target mRNA is normalized to the reference genes,
NMC0129 and NMC0139, and calculated in arbitrary units set
to a value of 1 for the wild-type strain. The specificity was checked
by analyzing the melting curves.
Electron microscopy
To analyze the structure of pili, we followed a previously
described protocol [7]. In brief, bacteria suspended in PBS were
adsorbed to formvar-coated grids for 5 min and fixed with 1%
glutaraldehyde for 5 min. After washing twice with water, grids
were incubated with 1% phosphotungstic acid for 2 min, air-dried
and analyzed using a TECNAI G2 Sprint BioTWIN electron
microscope (FEI).
Quantification of the bacterial aggregative ability
We followed a previously described protocol [7]. Bacteria grown
overnight on GC agar plates were resuspended GC liquid medium
or DMEM, filtered on 5 mm filters to eliminate large aggregates
and adjusted to an OD600 of 0.6 in 30 ml of the each medium.
Bacteria were then grown for 150 min under constant agitation.
Finally, these suspensions were left to sediment at room
temperature without shaking, and the OD600 of the supernatant
was measured at 20 min intervals.
Mouse model of meningococcal infection
Five to seven weeks old human CD46 transgenic mice
[33,34,47] were used as disease model. Bacteria grown overnight
on GC agar plates were resuspended in PBS, filtered through a
5 mm-filter and the viable counts were determined at once. To
study systemic disease, mice (n=6 in each group) were challenged
i.p. with 1610
8 CFU bacteria in 100 ml PBS. Mice were
monitored for 7 days in survival studies. Bacteremia was
determined by recovery of bacteria from blood samples taken
from the tail vein at different time points post challenge. This
experiment was repeated twice.
Whole blood killing assay
Whole blood was taken from the orbital vein of the mice and
heparinized. Bacterial colonies grown overnight on GC plates
were suspended in DMEM. Bacterial suspensions containing 10
2
CFU of N. meningitidis (10 ml) were mixed with 10 ml of blood and
incubated at 37uC in a 5% CO2 atmosphere for indicated time
periods. Bacterial suspensions were then plated on GC plates to
enumerate viable bacteria. Assays were performed twice in
triplicates and data show the ratio of the recovered bacteria
compared to the initial input.
Statistical analysis
The Student’s t-test was used in quantification of band
intensities (Fig. 3C), whole cell ELASA (Fig. 3D), adherence
efficiency experiment (Fig. 5) and whole blood killing assay
(Fig. 8C, 8D, and 8E). Bacterial counts in blood were analyzed
using non-parametric Mann-Whitney test (Fig. 8A). Survival rates
were assessed using the log rank test (Fig. 8B). Values of P,0.05
were considered significant.
Supporting Information
Figure S1 Construction of pDONR P4-P1R 5-porA-pro and
pDONR P2R-P3 CmR-3. A non-coding genomic region between
NMC0075 and NMC0080 was selected for insertion of the
complementary nafA gene by homologous allelic replacement. A
842 bp fragment containing a 502 bp upstream region and the
porA promoter generated by combination PCR (See Experimental
procedures) was cloned into pDONR P4-P1R to obtain pDONR
P4-P1R 5-porA-pro. A DNA uptake sequence (DUS) was
introduced at the 59 end of this fragment. A 1649 bp fragment
containing chloramphenicol resistance gene (Cm
R) and a 515 bp
downstream region obtained by combination PCR was cloned into
pDONR P2R-P3 to produce pDONR P2R-P3 CmR-3.
(PDF)
Figure S2 Construction of plasmid pDEST-nafA-comp using a
MultiSite Gateway strategy. A full-length nafA ORF was cloned
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procedures). Multiple fragments carried by plasmids pDONR P4-
P1R 5-porA-pro, pDONR nafA and pDONR P2R-P3 CmR-3
were assembled after mixing with the plasmid pDEST R4-R3
containing specific recombination sites and the LR clonase Plus
enzyme according to the supplier’s instruction. The resulting
plasmid pDEST-nafA-comp containing upstream region (59), porA
promoter (PporA), nafA ORF, chloramphenicol resistance gene
(Cm
R), and downstream region (39) was used to complement the
DNafA mutation via transformation.
(PDF)
Figure S3 Construction of a universal expression vector for N.
meningitidis and expression of the egfp gene in N. meningitidis FAM20.
A. The egfp ORF was PCR amplified from the pEGFP-C1 plasmid
(Clontech) with the primers B1-egfp (AAA AAG CAG GCT ATG
GTG AGC AAG GGC GAG GAG CTG TTC) and B2-egfp
(AGA AAG CTG GGT TTA TCT AGA TCC GGT GGA TCC
CGG G). To enhance the gene translation, an RBS-fused egfp
ORF was also amplified with the primers B1-RBS-egfp (AAA
AAG CAG GCT AGG AGG ATC CTAT G G TGA GCA AGG
GCG AGG AGC TGT TG) and B2-egfp. RBS is underlined and
the start codon of egfp gene is in bold. These two egfp containing
fragment were cloned into pDONR 201, resulting plasmids
pDONR egfp and pDONR RBS-egfp, respectively. The egfp ORF
was assembled with the upstream region containing the porA
promoter and the downstream fragment containing Cm
R after
mixing plasmids pDONR P4-P1R 5-porA-pro, pDONR egfp (or
pDONR RBS-egfp), pDONR P2R-P3 CmR-3, and pDEST R4-
R3 as described in Fig. S2. The resulting expression plasmid was
designated as pDEST-egfp or pDEST-(RBS)-egfp. B. egfp gene
expression detected by western blot analysis. Plasmid pDEST-egfp
or pDEST-RBS-egfp was transformed into E. coli DH10B and the
N. meningitidis strain FAM20. Bacterial cell lysates were prepared
and EGFP was detected using an anti-GFP monoclonal antibody
(Roche). Parental bacterial strains were used as negative control
(control). EGFP signal intensities from bacteria containing the
additional RBS (RBS-EGFP) were higher than those lacking the
additional RBS (EGFP) in both E. coli and N. meningitidis.
(PDF)
Figure S4 Anti-NafA antibody prepared in present study is
specific for NafA FaDu cells were infected with the wild-type strain
(left column, identical photos in Fig. 2) or the DNafA strain for 6 h
(right column). After washing away unbound bacteria, the cells
were stained with anti-NafA peptide N antibody. Fluorescent
(upper row) and Nomarski (lower row) images are shown. A 100 x
objective lens was used. The inset shows higher magnification of
the boxed area in the image.
(PDF)
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